These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22922775)

  • 1. Evaluation of adrenal reserve in children with acute lymphocytic leukemia treated with prednisone or dexamethasone.
    Kuperman H; Odone Filho V; Cristofani LM; Assis de Almeida MT; Setian N; Damiani D
    Horm Res Paediatr; 2012; 78(2):73-80. PubMed ID: 22922775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical impact of corticosteroid-induced adrenal suppression during treatment for acute lymphoblastic leukemia in children: a prospective observational study using the low-dose adrenocorticotropin test.
    Rix M; Birkebaek NH; Rosthøj S; Clausen N
    J Pediatr; 2005 Nov; 147(5):645-50. PubMed ID: 16291357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired adrenal function after glucocorticoid therapy in children with acute lymphoblastic leukemia.
    Petersen KB; Müller J; Rasmussen M; Schmiegelow K
    Med Pediatr Oncol; 2003 Aug; 41(2):110-4. PubMed ID: 12825213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of adrenal function in children with acute lymphoblastic leukemia following induction therapy with corticosteroid and other cytotoxic agents.
    Mahachoklertwattana P; Vilaiyuk S; Hongeng S; Okascharoen C
    J Pediatr; 2004 Jun; 144(6):736-40. PubMed ID: 15192618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia.
    Einaudi S; Bertorello N; Masera N; Farinasso L; Barisone E; Rizzari C; Corrias A; Villa A; Riva F; Saracco P; Pastore G
    Pediatr Blood Cancer; 2008 Mar; 50(3):537-41. PubMed ID: 17828747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the hypothalamic-pituitary-adrenal axis in children with leukemia before and after 6 weeks of high-dose glucocorticoid therapy.
    Kuperman H; Damiani D; Chrousos GP; Dichtchekenian V; Manna TD; Filho VO; Setian N
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2993-6. PubMed ID: 11443157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
    Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008727. PubMed ID: 29106702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of hypothalamic-pituitary-adrenal axis recovery after corticotherapy by using basal cortisol secretion].
    Silva IN; Cunha CF; Finch FL; Colosimo EA
    Arq Bras Endocrinol Metabol; 2006 Feb; 50(1):118-24. PubMed ID: 16628284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
    Gordijn MS; Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
    Cochrane Database Syst Rev; 2015 Aug; (8):CD008727. PubMed ID: 26282194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time course of recovery of adrenal function in children treated for leukemia.
    Felner EI; Thompson MT; Ratliff AF; White PC; Dickson BA
    J Pediatr; 2000 Jul; 137(1):21-4. PubMed ID: 10891816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
    Gordijn MS; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
    Cochrane Database Syst Rev; 2012 May; (5):CD008727. PubMed ID: 22592733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of adrenal insufficiency during treatment for childhood acute lymphoblastic leukemia.
    Vestergaard TR; Juul A; Lausten-Thomsen U; Lausen B; Hjalgrim H; Kvist TK; Andersen EW; Schmiegelow K
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):442-9. PubMed ID: 21792040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Is there a risk of steroid-induced adrenal deficit after induction treatment of acute lymphoblastic leukemia?].
    Bélien-Pallet V; Cabrol S; Fasola S; Petit A; Landman-Parker J; Auvrignon A; Leverger G
    Arch Pediatr; 2010 Dec; 17(12):1637-44. PubMed ID: 20943354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-dose oral dexamethasone in the emergency management of children with exacerbations of mild to moderate asthma.
    Altamimi S; Robertson G; Jastaniah W; Davey A; Dehghani N; Chen R; Leung K; Colbourne M
    Pediatr Emerg Care; 2006 Dec; 22(12):786-93. PubMed ID: 17198210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia.
    Hurwitz CA; Silverman LB; Schorin MA; Clavell LA; Dalton VK; Glick KM; Gelber RD; Sallan SE
    Cancer; 2000 Apr; 88(8):1964-9. PubMed ID: 10760775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term effects on linear growth and bone turnover in children randomized to receive prednisolone or dexamethasone.
    Ahmed SF; Tucker P; Mushtaq T; Wallace AM; Williams DM; Hughes IA
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):185-91. PubMed ID: 12153596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early adrenocortical recovery after glucocorticoid therapy in children with leukemia.
    Cunha Cde F; Silva IN; Finch FL
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2797-802. PubMed ID: 15181060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No advantage of dexamethasone over prednisolone for the outcome of standard- and intermediate-risk childhood acute lymphoblastic leukemia in the Tokyo Children's Cancer Study Group L95-14 protocol.
    Igarashi S; Manabe A; Ohara A; Kumagai M; Saito T; Okimoto Y; Kamijo T; Isoyama K; Kajiwara M; Sotomatsu M; Sugita K; Sugita K; Maeda M; Yabe H; Kinoshita A; Kaneko T; Hayashi Y; Ikuta K; Hanada R; Tsuchida M
    J Clin Oncol; 2005 Sep; 23(27):6489-98. PubMed ID: 16170158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential antileukemic activity of prednisolone and dexamethasone in freshly isolated leukemic cells.
    Mihál V; Hajdúch M; Nosková V; Feketová G; Jess K; Gojová L; Kaspárek I; Starý J; Blazek B; Pospísilová D; Novák Z
    Adv Exp Med Biol; 1999; 457():461-71. PubMed ID: 10500823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High incidence of adrenal suppression in children with Kawasaki disease treated with intravenous immunoglobulin plus prednisolone.
    Goto M; Miyagawa N; Kikunaga K; Miura M; Hasegawa Y
    Endocr J; 2015; 62(2):145-51. PubMed ID: 25342092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.